Coramaze Technologies

Filling the Cardiac Gap

Active A Startup Petah Tikva Founded 2018-01

Coramaze Technologies develops the Tripair, a simple, rapid, and effective percutaneous treatment for tricuspid valve disease. The treatment is intended to improve quality of life and reduce morbidity for heart failure patients suffering from tricuspid regurgitation. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrieva…

SectorHealth Tech & Life Sciences
StageA
Total raised$6.3M
Employees21
Founded2018-01
HQPetah Tikva
Patents1
Confidence97
Sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technology
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders